Myriad Genetics, a molecular diagnostic company, and biotechnology firm BioMarin Pharmaceutical have signed a research collaboration agreement for identifying tumor types that may be sensitive to BioMarin's investigational product ...
Tags: Myriad Genetics, Biomarin
Myriad Genetics, a US-based molecular diagnostic company, has launched a new prognostic test, Myriad myPlan Lung Cancer, for patients diagnosed with early-stage lung adenocarcinoma. myPlan lung cancer test is an RNA expression panel of 31 ...
Molecular diagnostic company Myriad Genetics has launched myRisk Hereditary Cancer, a new multi-gene diagnostic test for hereditary cancer testing. The new test analyses 25 genes that are associated with breast, colorectal, ovarian, ...
Tags: Multi-Gene Test, Medicine
BD Diagnostics, a molecular diagnostic company, has launched Trichomonas vaginalis molecular detection test for use on the BD Viper system in Europe. The test, BD ProbeTec Trichomonas vaginalis Qx Amplified DNA assay, is designed for the ...
Tags: molecular diagnostic, Trichomonas vaginalis molecular detection test